ISCHEMIC STROKE

Image

pRESET

ANEURYSM TREATMENT

ACCESS AND DELIVERY

TECHNOLOGIES

Image

HPC

Hydrophilic Polymer Coating

HPC is an aneurysm implant and Flow Diverter coating, which shall reduce the risk of thrombosis on the surface of stents. Due to the thrombogenic surface, platelet function-inhibiting drugs are needed to prevent in-stent thrombosis. The current solution of preventing platelet activation is the Dual Anti-Platelet Therapy (DAPT) consisting of Aspirin and Clopidogrel. HPC reduces the risk of thrombus formation on the implant by initially reducing or preventing the adhesion of platelets when in contact with blood. The whole implant is covered with an invisible coating.


For more information click here.

NEWS

Results of the international Diversion-p64 study: The largest real-world Flow Diverter experience – Recording is available!

30. November 2020
The ESMINT webinar provides the opportunity to meet experts, who share their experience, practice, and way of thinking regarding everyday challenges in the field of neurointerventions. Share this Post Results of the international Diversion-p64 study: the largest real-world Flow Diverter experience - Recording is available! On Monday, 30 November 2020,...
Read More

UPCOMING EVENTS

February

12Feb(Feb 12)0:0013(Feb 13)0:00VSNR 2021VSNR Frühjahrstagung 2021Baden-Baden

March

17Mar(Mar 17)0:0019(Mar 19)0:00ISC 2021International Stroke Conference Online

April

23Apr(Apr 23)0:0024(Apr 24)0:00GSANIT 2021Grupo Sud-Americano de Neuro-radiología Intervencionista y TerapéuticaBuenos Aires, Argentina

May

10May(May 10)0:0011(May 11)0:00SLICE - NEXT FRONTIERSSLICE - NEXT FRONTIERS - 100% OnlineOnline

September

01Sep0:0003(Sep 3)0:00ESOC 20217th European Stroke ConferenceHelsinki, Finland

OUR TREATMENT SOLUTIONS

ANEURYSM TREATMENT

ISCHEMIC STROKE

ACCESS AND DELIVERY